Dataset Information

Proteomic data from non-invasively collected samples of nevi and early melanoma

ABSTRACT: Data independent acquisition mass spectrometry-based proteomic data from non-invasively collected samples of benign nevi (n=11) and melanomas (n=19).

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Ali Azimi

PROVIDER: PXD044058 | JPOST Repository | Thu Jul 25 00:00:00 BST 2024

REPOSITORIES: jPOST

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 20

Similar Datasets

Project description:Neurologic manifestations are among the most frequently reported complications of COVID-19. However, given the paucity of tissue samples and highly infectious nature of the etiologic agent of COVID-19, we have limited information to understand the neuropathogenesis of COVID-19. Therefore to better understand the impact of COVID-19 in brain, we employed mass-spectrometry-based proteomics using data-independent acquisition mode (DIA) to investigate cerebrospinal fluid (CSF) proteins collected from two different non-human primates, Rhesus Macaque and African Green Monkeys for the neurologic effects of the infection. These monkeys exhibited minimal to mild pulmonary pathology but moderate to severe CNS pathology. Our results indicate that CSF proteome changes after infection resolution correspond with bronchial virus abundance during early infection and revealed substantial differences between the infected NHPs and their age-matched uninfected controls, suggesting these differences could reflect altered secretion of CNS factors in response to SARS-CoV-2-induced neuropathology. We also observed the infected animals to exhibit much scattered data distributions as compared to the tightly clustered corresponding controls which suggest the heterogeneity of the CSF proteome change and the host response to the viral infection. In addition, dysregulated CSF proteins were preferentially enriched in functional pathways associated with progressive neurodegenerative disorders, hemostasis and innate immune responses that could influence neuroinflammatory responses following COVID-19. Mapping dysregulated proteins to the Human Brain Protein Atlas found that these proteins tended to be enriched in brain regions that exhibit more frequent injury following COVID-19. It therefore appears reasonable to speculate that such CSF protein changes could serve as signatures for neurologic injury, identify important regulatory pathways in this process, and potentially reveal therapeutic targets to prevent or attenuate the development of neurologic injuries following COVID-19.

			Action	DRS
	103_IS_204.raw	Raw
	106_BN_031.raw	Raw
	130_BN_178.raw	Raw
	164_BN_218.raw	Raw
	175_BN_070.raw	Raw

Dataset Information

Proteomic data from non-invasively collected samples of nevi and early melanoma

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets